Revance Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Nashville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
Revance Therapeutics, Inc. has filed 947 SEC EDGAR filings since 23 Dec 2009

SEC filing history

Showing 376-400 of 946 matching filings.

Per page
25
Current page
16
SC 13G/A File 005-88023

SC 13G/A filing

Filing date
05 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Feb 2021
Reporting date
02 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Feb 2021
Reporting date
02 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Feb 2021
Reporting date
02 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Feb 2021
Reporting date
02 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Feb 2021
Reporting date
02 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Feb 2021
Reporting date
02 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88023

SEC SCHEDULE 13G

Filing date
04 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Feb 2021
Reporting date
01 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88023

SC 13G/A filing

Filing date
02 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88023

FILING REVANCE THERAPEUTICS, INC.

Filing date
29 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-252526

S-8

Filing date
29 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2021
Reporting date
30 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Dec 2020
Reporting date
15 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Dec 2020
Reporting date
15 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Dec 2020
Reporting date
30 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-250998

S-3ASR

Filing date
27 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .